25 XP   0   0   10

PharmAust Ltd
Buy, Hold or Sell?

Let's analyse Pharmaust together

PenkeI guess you are interested in PharmAust Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of PharmAust Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about PharmAust Ltd

I send you an email if I find something interesting about PharmAust Ltd.

Quick analysis of Pharmaust (30 sec.)










What can you expect buying and holding a share of Pharmaust? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
€0.01
Expected worth in 1 year
€-0.03
How sure are you?
70.0%

+ What do you gain per year?

Total Gains per Share
€-0.04
Return On Investment
-17.2%

For what price can you sell your share?

Current Price per Share
€0.24
Expected price per share
€0.0935 - €
How sure are you?
50%

1. Valuation of Pharmaust (5 min.)




Live pricePrice per Share (EOD)

€0.24

Intrinsic Value Per Share

€-0.04 - €-0.01

Total Value Per Share

€-0.03 - €0.00

2. Growth of Pharmaust (5 min.)




Is Pharmaust growing?

Current yearPrevious yearGrowGrow %
How rich?$4.2m$8.4m-$4.2m-101.7%

How much money is Pharmaust making?

Current yearPrevious yearGrowGrow %
Making money-$6.7m-$1.8m-$4.8m-72.5%
Net Profit Margin-220.0%-50.5%--

How much money comes from the company's main activities?

3. Financial Health of Pharmaust (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#777 / 1031

Most Revenue
#399 / 1031

Most Profit
#511 / 1031

Most Efficient
#672 / 1031

What can you expect buying and holding a share of Pharmaust? (5 min.)

Welcome investor! Pharmaust's management wants to use your money to grow the business. In return you get a share of Pharmaust.

What can you expect buying and holding a share of Pharmaust?

First you should know what it really means to hold a share of Pharmaust. And how you can make/lose money.

Speculation

The Price per Share of Pharmaust is €0.236. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Pharmaust.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Pharmaust, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €0.01. Based on the TTM, the Book Value Change Per Share is €-0.01 per quarter. Based on the YOY, the Book Value Change Per Share is €0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Pharmaust.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.02-7.3%-0.02-7.3%0.00-2.0%-0.01-2.9%-0.01-2.7%
Usd Book Value Change Per Share-0.01-4.6%-0.01-4.6%0.00-1.2%0.00-0.8%0.000.5%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.01-4.6%-0.01-4.6%0.00-1.2%0.00-0.8%0.000.5%
Usd Price Per Share0.04-0.04-0.04-0.05-0.04-
Price to Earnings Ratio-2.26--2.26--8.92--11.03--7.33-
Price-to-Total Gains Ratio-3.56--3.56--14.70-17.83-12.48-
Price to Book Ratio3.62-3.62-1.94-2.53-1.95-
Price-to-Total Gains Ratio-3.56--3.56--14.70-17.83-12.48-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.2552812
Number of shares3917
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.010.00
Usd Total Gains Per Share-0.010.00
Gains per Quarter (3917 shares)-42.91-7.05
Gains per Year (3917 shares)-171.63-28.20
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-172-1820-28-38
20-343-3540-56-66
30-515-5260-85-94
40-687-6980-113-122
50-858-8700-141-150
60-1030-10420-169-178
70-1201-12140-197-206
80-1373-13860-226-234
90-1545-15580-254-262
100-1716-17300-282-290

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%0.010.00.00.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%7.03.00.070.0%7.03.00.070.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.010.00.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%7.03.00.070.0%7.03.00.070.0%

Fundamentals of Pharmaust

About PharmAust Ltd

PharmAust Limited develops targeted cancer therapeutics for humans and animals in Switzerland, Australia, Sweden, the United States, and internationally. The company develops drug discovery intellectual property for the treatment of various cancers, neurological diseases, and viral infections. Its lead candidate is Monepantel (MPL), a small molecule drug which is in Phase II clinical trials for the treatment of cancer. The company also provides products and services in synthetic and medicinal chemistry to the drug discovery and pharmaceutical industries worldwide. It serves drug discovery and pharmaceutical industries. PharmAust Limited was incorporated in 2000 and is based in Bentley, Australia.

Fundamental data was last updated by Penke on 2024-03-27 16:36:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is very efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of PharmAust Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Pharmaust earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Pharmaust to the Biotechnology industry mean.
  • A Net Profit Margin of -220.0% means that €-2.20 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of PharmAust Ltd:

  • The MRQ is -220.0%. The company is making a huge loss. -2
  • The TTM is -220.0%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-220.0%TTM-220.0%0.0%
TTM-220.0%YOY-50.5%-169.4%
TTM-220.0%5Y-83.6%-136.4%
5Y-83.6%10Y-89.6%+6.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-220.0%-171.8%-48.2%
TTM-220.0%-205.8%-14.2%
YOY-50.5%-262.1%+211.6%
5Y-83.6%-455.6%+372.0%
10Y-89.6%-589.0%+499.4%
1.1.2. Return on Assets

Shows how efficient Pharmaust is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Pharmaust to the Biotechnology industry mean.
  • -101.3% Return on Assets means that Pharmaust generated €-1.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of PharmAust Ltd:

  • The MRQ is -101.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -101.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-101.3%TTM-101.3%0.0%
TTM-101.3%YOY-16.9%-84.4%
TTM-101.3%5Y-32.2%-69.1%
5Y-32.2%10Y-30.7%-1.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-101.3%-12.5%-88.8%
TTM-101.3%-12.2%-89.1%
YOY-16.9%-11.2%-5.7%
5Y-32.2%-13.4%-18.8%
10Y-30.7%-14.7%-16.0%
1.1.3. Return on Equity

Shows how efficient Pharmaust is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Pharmaust to the Biotechnology industry mean.
  • -159.7% Return on Equity means Pharmaust generated €-1.60 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of PharmAust Ltd:

  • The MRQ is -159.7%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -159.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-159.7%TTM-159.7%0.0%
TTM-159.7%YOY-21.8%-137.9%
TTM-159.7%5Y-46.7%-113.0%
5Y-46.7%10Y-40.5%-6.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-159.7%-15.8%-143.9%
TTM-159.7%-15.7%-144.0%
YOY-21.8%-13.9%-7.9%
5Y-46.7%-18.3%-28.4%
10Y-40.5%-19.2%-21.3%

1.2. Operating Efficiency of PharmAust Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Pharmaust is operating .

  • Measures how much profit Pharmaust makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Pharmaust to the Biotechnology industry mean.
  • An Operating Margin of -115.2% means the company generated €-1.15  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of PharmAust Ltd:

  • The MRQ is -115.2%. The company is operating very inefficient. -2
  • The TTM is -115.2%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-115.2%TTM-115.2%0.0%
TTM-115.2%YOY-47.9%-67.3%
TTM-115.2%5Y-60.6%-54.6%
5Y-60.6%10Y-77.9%+17.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-115.2%-299.1%+183.9%
TTM-115.2%-210.1%+94.9%
YOY-47.9%-279.7%+231.8%
5Y-60.6%-459.9%+399.3%
10Y-77.9%-596.9%+519.0%
1.2.2. Operating Ratio

Measures how efficient Pharmaust is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.28 means that the operating costs are €0.28 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of PharmAust Ltd:

  • The MRQ is 0.279. The company is very efficient in keeping operating costs low. +2
  • The TTM is 0.279. The company is very efficient in keeping operating costs low. +2
Trends
Current periodCompared to+/- 
MRQ0.279TTM0.2790.000
TTM0.279YOY0.093+0.186
TTM0.2795Y0.431-0.152
5Y0.43110Y1.180-0.749
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2792.861-2.582
TTM0.2793.193-2.914
YOY0.0933.615-3.522
5Y0.4315.560-5.129
10Y1.1807.396-6.216

1.3. Liquidity of PharmAust Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Pharmaust is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 2.24 means the company has €2.24 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of PharmAust Ltd:

  • The MRQ is 2.242. The company is able to pay all its short-term debts. +1
  • The TTM is 2.242. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.242TTM2.2420.000
TTM2.242YOY3.200-0.958
TTM2.2425Y3.469-1.226
5Y3.46910Y3.662-0.193
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.2423.986-1.744
TTM2.2424.440-2.198
YOY3.2005.552-2.352
5Y3.4696.158-2.689
10Y3.6626.492-2.830
1.3.2. Quick Ratio

Measures if Pharmaust is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Pharmaust to the Biotechnology industry mean.
  • A Quick Ratio of 0.17 means the company can pay off €0.17 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of PharmAust Ltd:

  • The MRQ is 0.168. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.168. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.168TTM0.1680.000
TTM0.168YOY0.159+0.009
TTM0.1685Y0.238-0.070
5Y0.23810Y0.254-0.016
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1683.638-3.470
TTM0.1684.168-4.000
YOY0.1595.515-5.356
5Y0.2386.012-5.774
10Y0.2546.209-5.955

1.4. Solvency of PharmAust Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Pharmaust assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Pharmaust to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.37 means that Pharmaust assets are financed with 36.6% credit (debt) and the remaining percentage (100% - 36.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of PharmAust Ltd:

  • The MRQ is 0.366. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.366. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.366TTM0.3660.000
TTM0.366YOY0.222+0.144
TTM0.3665Y0.223+0.142
5Y0.22310Y0.174+0.049
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3660.335+0.031
TTM0.3660.330+0.036
YOY0.2220.267-0.045
5Y0.2230.367-0.144
10Y0.1740.378-0.204
1.4.2. Debt to Equity Ratio

Measures if Pharmaust is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Pharmaust to the Biotechnology industry mean.
  • A Debt to Equity ratio of 57.6% means that company has €0.58 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of PharmAust Ltd:

  • The MRQ is 0.576. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.576. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.576TTM0.5760.000
TTM0.576YOY0.285+0.292
TTM0.5765Y0.302+0.275
5Y0.30210Y0.224+0.077
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5760.376+0.200
TTM0.5760.398+0.178
YOY0.2850.334-0.049
5Y0.3020.429-0.127
10Y0.2240.476-0.252

2. Market Valuation of PharmAust Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Pharmaust generates.

  • Above 15 is considered overpriced but always compare Pharmaust to the Biotechnology industry mean.
  • A PE ratio of -2.26 means the investor is paying €-2.26 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of PharmAust Ltd:

  • The EOD is -14.840. Based on the earnings, the company is expensive. -2
  • The MRQ is -2.264. Based on the earnings, the company is expensive. -2
  • The TTM is -2.264. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-14.840MRQ-2.264-12.576
MRQ-2.264TTM-2.2640.000
TTM-2.264YOY-8.917+6.654
TTM-2.2645Y-11.030+8.766
5Y-11.03010Y-7.335-3.695
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-14.840-2.643-12.197
MRQ-2.264-2.418+0.154
TTM-2.264-2.742+0.478
YOY-8.917-4.123-4.794
5Y-11.030-6.257-4.773
10Y-7.335-6.478-0.857
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of PharmAust Ltd:

  • The EOD is -57.644. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -8.793. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -8.793. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-57.644MRQ-8.793-48.851
MRQ-8.793TTM-8.7930.000
TTM-8.793YOY-11.073+2.280
TTM-8.7935Y-13.644+4.850
5Y-13.64410Y-8.140-5.503
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-57.644-3.244-54.400
MRQ-8.793-2.939-5.854
TTM-8.793-3.478-5.315
YOY-11.073-5.592-5.481
5Y-13.644-8.473-5.171
10Y-8.140-8.881+0.741
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Pharmaust is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 3.62 means the investor is paying €3.62 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of PharmAust Ltd:

  • The EOD is 23.702. Based on the equity, the company is expensive. -2
  • The MRQ is 3.616. Based on the equity, the company is fair priced.
  • The TTM is 3.616. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD23.702MRQ3.616+20.086
MRQ3.616TTM3.6160.000
TTM3.616YOY1.942+1.674
TTM3.6165Y2.529+1.086
5Y2.52910Y1.951+0.578
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD23.7022.124+21.578
MRQ3.6162.041+1.575
TTM3.6162.118+1.498
YOY1.9422.915-0.973
5Y2.5293.682-1.153
10Y1.9514.114-2.163
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of PharmAust Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.010-0.0100%-0.003-74%-0.002-84%0.001-1117%
Book Value Per Share--0.0100.0100%0.020-50%0.019-47%0.019-46%
Current Ratio--2.2422.2420%3.200-30%3.469-35%3.662-39%
Debt To Asset Ratio--0.3660.3660%0.222+65%0.223+64%0.174+110%
Debt To Equity Ratio--0.5760.5760%0.285+102%0.302+91%0.224+157%
Dividend Per Share----0%-0%-0%-0%
Eps---0.016-0.0160%-0.004-72%-0.006-61%-0.006-63%
Free Cash Flow Per Share---0.004-0.0040%-0.004-14%-0.004-12%-0.004-4%
Free Cash Flow To Equity Per Share--0.0010.0010%-0.002+308%0.000+75%0.001+11%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---0.011--------
Intrinsic Value_10Y_min---0.036--------
Intrinsic Value_1Y_max---0.003--------
Intrinsic Value_1Y_min---0.004--------
Intrinsic Value_3Y_max---0.007--------
Intrinsic Value_3Y_min---0.011--------
Intrinsic Value_5Y_max---0.010--------
Intrinsic Value_5Y_min---0.018--------
Market Cap92178768.000+85%14061168.00014061168.0000%15232932.000-8%17920177.440-22%13022203.920+8%
Net Profit Margin---2.200-2.2000%-0.505-77%-0.836-62%-0.896-59%
Operating Margin---1.152-1.1520%-0.479-58%-0.606-47%-0.779-32%
Operating Ratio--0.2790.2790%0.093+200%0.431-35%1.180-76%
Pb Ratio23.702+85%3.6163.6160%1.942+86%2.529+43%1.951+85%
Pe Ratio-14.840-556%-2.264-2.2640%-8.917+294%-11.030+387%-7.335+224%
Price Per Share0.236+85%0.0360.0360%0.039-8%0.046-22%0.033+8%
Price To Free Cash Flow Ratio-57.644-556%-8.793-8.7930%-11.073+26%-13.644+55%-8.140-7%
Price To Total Gains Ratio-23.305-556%-3.555-3.5550%-14.703+314%17.831-120%12.482-128%
Quick Ratio--0.1680.1680%0.159+6%0.238-30%0.254-34%
Return On Assets---1.013-1.0130%-0.169-83%-0.322-68%-0.307-70%
Return On Equity---1.597-1.5970%-0.218-86%-0.467-71%-0.405-75%
Total Gains Per Share---0.010-0.0100%-0.003-74%-0.002-84%0.001-1117%
Usd Book Value--4206877.3304206877.3300%8485324.258-50%7917222.341-47%7818089.620-46%
Usd Book Value Change Per Share---0.011-0.0110%-0.003-74%-0.002-84%0.001-1117%
Usd Book Value Per Share--0.0110.0110%0.022-50%0.020-47%0.020-46%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.017-0.0170%-0.005-72%-0.007-61%-0.006-63%
Usd Free Cash Flow---1729755.124-1729755.1240%-1488031.951-14%-1525567.807-12%-1166519.234-33%
Usd Free Cash Flow Per Share---0.004-0.0040%-0.004-14%-0.004-12%-0.004-4%
Usd Free Cash Flow To Equity Per Share--0.0010.0010%-0.002+308%0.000+75%0.001+11%
Usd Market Cap99709773.346+85%15209965.42615209965.4260%16477462.544-8%19384255.937-22%14086117.980+8%
Usd Price Per Share0.255+85%0.0390.0390%0.042-8%0.050-22%0.036+8%
Usd Profit---6719044.452-6719044.4520%-1847769.675-72%-2632920.755-61%-2510169.655-63%
Usd Revenue--3054619.1203054619.1200%3657523.004-16%3290931.196-7%2949359.759+4%
Usd Total Gains Per Share---0.011-0.0110%-0.003-74%-0.002-84%0.001-1117%
 EOD+5 -3MRQTTM+0 -0YOY+5 -285Y+4 -2910Y+8 -25

3.2. Fundamental Score

Let's check the fundamental score of PharmAust Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-14.840
Price to Book Ratio (EOD)Between0-123.702
Net Profit Margin (MRQ)Greater than0-2.200
Operating Margin (MRQ)Greater than0-1.152
Quick Ratio (MRQ)Greater than10.168
Current Ratio (MRQ)Greater than12.242
Debt to Asset Ratio (MRQ)Less than10.366
Debt to Equity Ratio (MRQ)Less than10.576
Return on Equity (MRQ)Greater than0.15-1.597
Return on Assets (MRQ)Greater than0.05-1.013
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of PharmAust Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5058.838
Ma 20Greater thanMa 500.187
Ma 50Greater thanMa 1000.147
Ma 100Greater thanMa 2000.100
OpenGreater thanClose0.184
Total4/5 (80.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-06-302020-06-302021-06-302022-06-302023-06-30
Total Other Income Expense Net 6762489245921,517-3881,129-3,639-2,510



Latest Balance Sheet

Balance Sheet of 2023-06-30. Currency in EUR. All numbers in thousands.

Summary
Total Assets6,130
Total Liabilities2,241
Total Stockholder Equity3,889
 As reported
Total Liabilities 2,241
Total Stockholder Equity+ 3,889
Total Assets = 6,130

Assets

Total Assets6,130
Total Current Assets3,021
Long-term Assets3,109
Total Current Assets
Cash And Cash Equivalents 2,706
Net Receivables 226
Other Current Assets 66
Total Current Assets  (as reported)3,021
Total Current Assets  (calculated)2,998
+/- 23
Long-term Assets
Property Plant Equipment 2
Intangible Assets 3,107
Long-term Assets  (as reported)3,109
Long-term Assets  (calculated)3,109
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities1,347
Long-term Liabilities894
Total Stockholder Equity3,889
Total Current Liabilities
Accounts payable 926
Total Current Liabilities  (as reported)1,347
Total Current Liabilities  (calculated)926
+/- 421
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt1,049
Long-term Liabilities  (as reported)894
Long-term Liabilities  (calculated)1,049
+/- 155
Total Stockholder Equity
Common Stock57,633
Retained Earnings -56,459
Other Stockholders Equity 2,715
Total Stockholder Equity (as reported)3,889
Total Stockholder Equity (calculated)3,889
+/-0
Other
Capital Stock57,633
Common Stock Shares Outstanding 347,475
Net Invested Capital 3,889
Net Tangible Assets 782
Net Working Capital 1,674
Property Plant and Equipment Gross 1,654



Balance Sheet

Currency in EUR. All numbers in thousands.

 Trend2023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-30
> Total Assets 
8,210
9,522
6,257
8,195
8,358
8,596
10,746
10,954
10,078
6,130
6,13010,07810,95410,7468,5968,3588,1956,2579,5228,210
   > Total Current Assets 
2,452
3,732
1,330
3,344
2,756
3,020
4,070
4,357
3,731
3,021
3,0213,7314,3574,0703,0202,7563,3441,3303,7322,452
       Cash And Cash Equivalents 
2,304
3,412
882
2,590
1,875
2,091
2,880
3,020
2,416
2,706
2,7062,4163,0202,8802,0911,8752,5908823,4122,304
       Short-term Investments 
2
4
4
4
6
4
0
0
0
0
0000464442
       Net Receivables 
104
287
94
259
286
289
298
242
185
226
22618524229828928625994287104
       Other Current Assets 
0
0
4
4
59
59
13
20
19
66
6619201359594400
   > Long-term Assets 
0
0
4,927
4,851
5,602
5,576
6,676
6,597
6,347
3,109
3,1096,3476,5976,6765,5765,6024,8514,92700
       Property Plant Equipment 
578
611
1,820
1,744
2,494
2,468
3,569
3,455
3,238
2
23,2383,4553,5692,4682,4941,7441,820611578
       Intangible Assets 
5,179
5,179
3,107
3,107
3,107
3,107
3,107
3,142
3,110
3,107
3,1073,1103,1423,1073,1073,1073,1073,1075,1795,179
> Total Liabilities 
445
683
1,234
1,280
1,220
1,140
2,220
2,073
2,234
2,241
2,2412,2342,0732,2201,1401,2201,2801,234683445
   > Total Current Liabilities 
406
664
735
956
1,193
922
1,058
911
1,166
1,347
1,3471,1669111,0589221,193956735664406
       Short-term Debt 
71
39
150
206
425
143
0
0
0
0
00001434252061503971
       Short Long Term Debt 
71
39
150
206
425
143
179
38
210
0
0210381791434252061503971
       Accounts payable 
230
460
397
362
617
673
557
559
604
926
926604559557673617362397460230
       Other Current Liabilities 
0
0
0
0
0
106
0
0
0
0
000010600000
   > Long-term Liabilities 
0
0
499
324
27
218
1,162
1,162
1,068
894
8941,0681,1621,1622182732449900
       Other Liabilities 
0
11
49
43
26
37
45
30
31
3
331304537264349110
> Total Stockholder Equity
7,764
8,839
5,023
6,915
7,138
7,456
8,526
8,880
7,844
3,889
3,8897,8448,8808,5267,4567,1386,9155,0238,8397,764
   Common Stock
41,393
44,393
44,463
47,605
49,371
51,388
53,772
55,326
55,344
57,633
57,63355,34455,32653,77251,38849,37147,60544,46344,39341,393
   Retained Earnings -56,459-50,247-48,539-47,202-45,840-44,289-41,767-40,423-36,496-34,571
   Capital Surplus 0000000000
   Treasury Stock0000000000
   Other Stockholders Equity 
942
942
983
1,077
2,055
1,907
1,956
2,093
2,748
2,715
2,7152,7482,0931,9561,9072,0551,077983942942



Balance Sheet

Currency in EUR. All numbers in thousands.




Cash Flow

Currency in EUR. All numbers in thousands.




Income Statement

Currency in EUR. All numbers in thousands.


Latest Income Statement (annual, 2023-06-30)

Gross Profit (+$)
totalRevenue2,824
Cost of Revenue-788
Gross Profit2,0362,036
 
Operating Income (+$)
Gross Profit2,036
Operating Expense--
Operating Income-3,7012,036
 
Operating Expense (+$)
Research Development1,032
Selling General Administrative4,301
Selling And Marketing Expenses-
Operating Expense-5,332
 
Net Interest Income (+$)
Interest Income81
Interest Expense-82
Other Finance Cost-0
Net Interest Income-1
 
Pretax Income (+$)
Operating Income-3,701
Net Interest Income-1
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-6,212-1,190
EBIT - interestExpense = -3,336
-6,212
-6,130
Interest Expense82
Earnings Before Interest and Taxes (EBIT)-3,254-6,130
Earnings Before Interest and Taxes (EBITDA)-5,803
 
After tax Income (+$)
Income Before Tax-6,212
Tax Provision-0
Net Income From Continuing Ops-6,212-6,212
Net Income-6,212
Net Income Applicable To Common Shares-6,212
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-2,5101
 

Technical Analysis of Pharmaust
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Pharmaust. The general trend of Pharmaust is BULLISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Pharmaust's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (100.0%) Bearish trend (-100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of PharmAust Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: .

The bearish price targets are: 0.173 > 0.145 > 0.0935.

Tweet this
PharmAust Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of PharmAust Ltd. The current mas is .

The long score for the Moving Averages is 14/14.
The longshort score for the Moving Averages is 14/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

PharmAust Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of PharmAust Ltd. The current macd is 0.01760151.

The long score for the Moving Average Convergence/Divergence (MACD) is 2/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 0/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Pharmaust price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Pharmaust. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Pharmaust price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
PharmAust Ltd Daily Moving Average Convergence/Divergence (MACD) ChartPharmAust Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of PharmAust Ltd. The current adx is 47.46.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Pharmaust shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
PharmAust Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of PharmAust Ltd. The current sar is 0.18035862.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
PharmAust Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of PharmAust Ltd. The current rsi is 58.84. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
PharmAust Ltd Daily Relative Strength Index (RSI) ChartPharmAust Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of PharmAust Ltd. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Pharmaust price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
PharmAust Ltd Daily Stochastic Oscillator ChartPharmAust Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of PharmAust Ltd. The current cci is 119.15.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
PharmAust Ltd Daily Commodity Channel Index (CCI) ChartPharmAust Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of PharmAust Ltd. The current cmo is 19.23.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
PharmAust Ltd Daily Chande Momentum Oscillator (CMO) ChartPharmAust Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of PharmAust Ltd. The current willr is -12.5.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
PharmAust Ltd Daily Williams %R ChartPharmAust Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of PharmAust Ltd.

PharmAust Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of PharmAust Ltd. The current atr is 0.02670399.

PharmAust Ltd Daily Average True Range (ATR) ChartPharmAust Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of PharmAust Ltd. The current obv is -2,473,050.

PharmAust Ltd Daily On-Balance Volume (OBV) ChartPharmAust Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of PharmAust Ltd. The current mfi is 70.83.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
PharmAust Ltd Daily Money Flow Index (MFI) ChartPharmAust Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for PharmAust Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-07 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-08 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-10 00:00:00RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-14 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-15 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-11-16 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-17 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-20 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-24 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-27 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-28 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-11-30 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-01 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-05 00:00:00BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-06 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-07 00:00:00RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-08 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-12 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-13 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-14 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-15 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-20 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-21 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-02 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-08 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-11 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-16 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-17 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-18 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-19 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-22 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-23 00:00:00ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-24 00:00:00RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-25 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-29 00:00:00RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-31 00:00:00RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-02 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-07 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-08 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-09 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-12 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-13 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-14 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-15 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-16 00:00:00MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-19 00:00:00BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-20 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-21 00:00:00RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-22 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-23 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-26 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27 00:00:00MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-28 00:00:00RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-01 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-04 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-05 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-06 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-08 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11 00:00:00CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-13 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-14 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-15 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-18 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-19 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-20 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-21 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-22 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-25 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-27 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

PharmAust Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of PharmAust Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5058.838
Ma 20Greater thanMa 500.187
Ma 50Greater thanMa 1000.147
Ma 100Greater thanMa 2000.100
OpenGreater thanClose0.184
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Pharmaust with someone you think should read this too:
  • Are you bullish or bearish on Pharmaust? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Pharmaust? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about PharmAust Ltd

I send you an email if I find something interesting about PharmAust Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about PharmAust Ltd.

Receive notifications about PharmAust Ltd in your mailbox!